Shell Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $534K | Sell |
7,936
-27,876
| -78% | -$2.21M | 0.05% | 332 |
|
|
2025
Q2 | $3.13M | Buy |
35,812
+5,138
| +17% | +$403K | 0.11% | 190 |
|
|
2025
Q1 | $2.1M | Sell |
30,674
-1,026
| -3% | -$83.7K | 0.1% | 192 |
|
|
2024
Q4 | $2.46M | Sell |
31,700
-1,509
| -5% | -$112K | 0.11% | 169 |
|
|
2024
Q3 | $2.23M | Buy |
+33,209
| New | +$2.73M | 0.1% | 183 |
|
|
2024
Q1 | $3.57M | Sell |
31,521
-5,789
| -16% | -$728K | 0.16% | 116 |
|
|
2023
Q4 | $4.63M | Sell |
37,310
-9,727
| -21% | -$994K | 0.21% | 95 |
|
|
2023
Q3 | $4.39M | Sell |
47,037
-1,077
| -2% | -$121K | 0.18% | 110 |
|
|
2023
Q2 | $6.18M | Buy |
48,114
+21,821
| +83% | +$2.64M | 0.24% | 72 |
|
|
2023
Q1 | $3.06M | Sell |
26,293
-325
| -1% | -$36.4K | 0.13% | 170 |
|
|
2022
Q4 | $3.01M | Sell |
26,618
-4,533
| -15% | -$498K | 0.13% | 166 |
|
|
2022
Q3 | $2.51M | Sell |
31,151
-7,497
| -19% | -$635K | 0.1% | 213 |
|
|
2022
Q2 | $2.88M | Buy |
38,648
+4,808
| +14% | +$439K | 0.09% | 235 |
|
|
2022
Q1 | $4.33M | Sell |
33,840
-2,564
| -7% | -$280K | 0.1% | 203 |
|
|
2021
Q4 | $4.89M | Buy |
36,404
+4,224
| +13% | +$607K | 0.1% | 204 |
|
|
2021
Q3 | $4.4M | Sell |
32,180
-572
| -2% | -$72.1K | 0.1% | 211 |
|
|
2021
Q2 | $3.5M | Sell |
32,752
-504
| -2% | -$48.4K | 0.07% | 269 |
|
|
2021
Q1 | $2.99M | Sell |
33,256
-5,216
| -14% | -$490K | 0.06% | 295 |
|
|
2020
Q4 | $3.56M | Buy |
38,472
+15,464
| +67% | +$1.38M | 0.07% | 284 |
|
|
2020
Q3 | $2.37M | Buy |
23,008
+11,364
| +98% | +$1.19M | 0.06% | 311 |
|
|
2020
Q2 | $1.18M | Sell |
11,644
-4,520
| -28% | -$404K | 0.03% | 408 |
|
|
2020
Q1 | $1.09M | Sell |
16,164
-2,564
| -14% | -$160K | 0.03% | 408 |
|
|
2019
Q4 | $1.02M | Sell |
18,728
-6,100
| -25% | -$289K | 0.02% | 544 |
|
|
2019
Q3 | $926K | Hold |
24,828
| – | – | 0.02% | 568 |
|
|
2019
Q2 | $930K | Sell |
24,828
-23,364
| -48% | -$734K | 0.02% | 595 |
|
|
2019
Q1 | $1.44M | Sell |
48,192
-16,192
| -25% | -$569K | 0.03% | 422 |
|
|
2018
Q4 | $1.93M | Buy |
64,384
+21,628
| +51% | +$686K | 0.05% | 343 |
|
|
2018
Q3 | $1.53M | Buy |
+42,756
| New | +$1.33M | 0.03% | 469 |
|
|
2017
Q4 | – | Sell |
-20,120
| Closed | -$246K | – | 1114 |
|
|
2017
Q3 | $246K | Sell |
20,120
-3,104
| -13% | -$54.9K | 0.01% | 1015 |
|
|
2017
Q2 | $425K | Sell |
23,224
-72,324
| -76% | -$1.34M | 0.01% | 941 |
|
|
2017
Q1 | $2.02M | Buy |
95,548
+9,256
| +11% | +$181K | 0.04% | 370 |
|
|
2016
Q4 | $1.29M | Buy |
+86,292
| New | +$1.53M | 0.03% | 548 |
|
Other funds holding DXCM
N
Shell Asset Management's DXCM Position: Q3 2025 in Review
Shell Asset Management reduced its DexCom (DXCM) stake by 78% in Q3 2025, selling an estimated $2.21M and leaving 7,936 shares worth $534K. The position accounts for 0.05% of the portfolio, ranked #332.
Shell Asset Management first reported a position in DXCM in Q4 2016 and has held it in 32 quarters since. The position peaked at $6.18M in Q2 2023. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.
- Shell Asset Management held 7,936 shares of DexCom worth $534K as of Q3 2025.
- Shell Asset Management sold 27,876 DexCom shares in Q3 2025, an estimated $2.21M.
- DexCom made up 0.05% of Shell Asset Management's portfolio in Q3 2025, its #332 holding.
- Shell Asset Management first reported a position in DexCom in Q4 2016 and has held it in 32 quarters since.
- Shell Asset Management's DexCom position peaked at $6.18M in Q2 2023.
- 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.